| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.2 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |